Start | Browse by Day | Author Index

321 Efficacy and safety of omalizumab added to optimized asthma care in children with inadequately controlled allergic asthma

Sunday, April 26, 2009
B. Lanier Jr., MD , University of North Texas, Fort Worth, TX
T. Bridges, MD , Georgia Pollens Clinical Research Centers Inc, Albany, GA
M. Kulus, MD , Medical University of Warsaw, Warsaw, Poland
A. FowlerTaylor, RPh , Novartis Pharmaceuticals Corporation, East Hanover, NJ
M. Blogg, MD , Novartis Horsham Research Centre, Horsham, United Kingdom
R. Maykut, MD , Novartis Pharmaceuticals Corporation, East Hanover, NJ
M. Massanari, PharmD , Novartis Pharmaceuticals Corporation, East Hanover, NJ
P. Jimenez, MD , Novartis Pharmaceuticals Corporation, East Hanover, NJ
See more of: Scientific Poster Presentations #2
See more of: Late Breakers
<< Previous Abstract | Next Abstract >>